NM_000032.5:c.1699A>G
Variant summary
Our verdict is Uncertain significance. Variant got 5 ACMG points: 5P and 0B. PM2PP3PP5_Moderate
The NM_000032.5(ALAS2):c.1699A>G(p.Met567Val) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★).
Frequency
Consequence
NM_000032.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 5 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 22
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 22
ClinVar
Submissions by phenotype
not provided Pathogenic:1
p.Met567Val (ATG>GTG): c.1699 A>G in exon 11 of the ALAS2 gene (NM_000032.4). The M567V missense mutation in the ALAS2 gene has been reported previously in a patient with X-linked hereditary sideroblastic anemia (Bishop et al., 2012). Functional studies suggest that the mutation interferes with binding between ALAS2 and succinyl-CoA synthase and disrupts the complex (Bishop et al., 2012). This complex is hypothesized to play an important role in in vivo heme biosynthesis. This result is expected to be consistent with a diagnosis of X-linked hereditary sideroblastic anemia. The variant is found in MITONUC-MITOP panel(s). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at